Treatment for AML | Official Physician Website
赞助HCPs - See How mIDH1 Can Lead to Poor Prognosis in Acute Myeloid Leukemia. Learn About A Targeted Treatment Option for Your Patients With Acute Myeloid Leukemia.Newly Diagnosed AML Treatment | IDH-Targeted Treatment Option
赞助Visit The Site To Learn About A Targeted Treatment For Newly Diagnosed or R/R AML. Learn About A Targeted Treatment Option For Patients With Newly Diagnosed or R/R AML.
某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果
AML Treatment Option | Diagnosing Patients With AML
赞助Healthcare Professionals: Discover a Treatment Option for Patients With FLT3-Mutated AML. Physicians: Learn About The Mechanism of Action for an AML Treatment Option.Guideline Recommendations · AML Treatment Option · Dosing Guide · Safety & Efficacy Info
Types: Important Safety Info, Resources and Support, Prescribing InformationAbout XOSPATA® (gilteritinib) | Official HCP Website
赞助View Important Safety Information Including Boxed Warning for XOSPATA® (gilteritinib). Access Prescribing and Dosing Info, Including Other HCP Resources on the Official Website.Efficacy Data · Boxed Warning · Adverse Reactions · Learn More About XOSPATA®
Types: Resources & Support, Efficacy Data, Support Solutions℠, XOSPATA Quick Start+®
反馈